Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex vs Neostigmine for Recovery in Elderly Vitrectomy Patients
NCT03108989Completed
- Sponsor
- Yonsei University
- Start
- Feb 2017
- Primary completion
- Jul 2017
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
Randomised trial of Sugammadex in neuromuscular blockade (NMB) (2 arms), sponsored by Yonsei University. Primary endpoint: Physiological domain of Postoperative Quality of Recovery Scale (PQRS) recovery. Started Feb 2017; status: completed.
02
Drugs
Sugammadex
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT03108989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03108989.